Navigation Links
Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis
Date:2/2/2008

ity."

The primary endpoint of the Phase 3, Multicenter, Randomized, Double- blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis Followed by Long-term Extension (PHOENIX 1) study examined the proportion of patients achieving at least a 75 percent improvement from baseline at week 12. Investigators reported findings from PHOENIX 1 that showed at week 12, after two doses, 67 percent of patients receiving 45 mg ustekinumab and 66 percent of patients receiving 90 mg ustekinumab achieved PASI 75 compared with 3 percent of patients receiving placebo (P<0.001 for each comparison versus placebo). Furthermore, 42 percent of patients in the 45 mg ustekinumab dosing group and 37 percent of patients in the 90 mg ustekinumab dosing group achieved PASI 90, or nearly complete clearance of psoriasis, compared with 2 percent of patients receiving placebo (P<0.001). Primary endpoint study findings from PHOENIX 1 were consistent with the week 12 primary endpoint findings reported at the World Congress of Dermatology in October 2007 from another study, the Phase 3, Multicenter, Randomized, Double- blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis Followed by Long-term Extension 2 (PHOENIX 2).

In the PHOENIX 1 study, subjects who received 45 mg or 90 mg of ustekinumab and consistently achieved a 75 percent improvement from baseline were randomized at week 40 to either continue treatment or switch to placebo, with levels of response to maintenance therapy measured at week 52. Of those patients who continued treatment with ustekinumab 45 mg and ustekinumab 90 mg dosing, 87 percent and 91 percent, respectively, had a sustained PASI 75 response compared with 64 percent and 62 percent of patients switched to placebo (P less than or equal to 0.001 for 45 mg comparison; P<0.00
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
2. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
3. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
4. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
5. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
6. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
8. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
9. Inverseon Announces Positive Phase IIa Asthma Study
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 As per the new ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 ... billion in 2014, growing at a CAGR of 13.2% from ... 2021. The global bionics market is growing primarily ... is leading to paralysis or amputation of body parts. In ...
(Date:7/27/2015)... , July 27, 2015 The Physician-Patient Alliance ... PPAHS posted its first blog on July 27, ... heart beat? ". This post featured what ... attack outside of a grocery store in Goodhue, ... 96-minute CPR marathon involving 20 others, who took turns pumping ...
(Date:7/27/2015)... MENLO PARK, Calif. , July 27, ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... in new orphan drug indications, today announced that ... investors for a registered direct placement ("Placement") of ... million common stock purchase warrants for aggregate purchases ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Physician-Patient Alliance for Health & Safety Turns 4 Years Old 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3
(Date:7/28/2015)... ... ... Advanced Fertility Center of Texas (AFCT) has hosted the EMBCOL office since the ... Laboratory Director at AFCT, was one of the founders of EMBCOL and served as ... credited with the discovery of intra-cytoplasmic sperm injection (ICSI) , which has revolutionized ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Intellitec Solutions ... Accounting Today’s annual ranking of Value Added Resellers of ERP Software is a look ... are presented with. This honor represents the second such award in 2015 for Intellitec ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Nurses across all ... time, up to 57 million Americans may need mental health services (SAMHSA, 2013) and ... Psychiatric-mental health RNs are one of the largest workforces who provide care ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... 2015 NoSQL Now! Conference, August 18-20 at the McHenry Convention Center in ... and exhibiting in booth #104. , Scientel’s presentation on Multi-Modeling and the industry’s first ...
(Date:7/28/2015)... ... ... President of the Veterans Fund of the United States, managing the United Veteran Beacon House ... a campaign to help homeless Veterans by giving them “A hand up – not a ... the UVBH assists and supports Vets through the Veterans Fund of the United States ...
Breaking Medicine News(10 mins):Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 3Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 4Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3
... An estimated 2.7 million people in the United States ... as chronic olfactory dysfunction. // Head trauma, viral infection, ... or normal aging can cause chronic olfactory dysfunction. ... or smell, you know how different you feel. Some ...
... results when too much uric acid builds up in the ... to meat and yes // to low-fat dairy if you ... rich in dairy products and low in beef, pork, lamb ... lies in the high purine content of many meats and ...
... researchers have found that certain hormones in the body ... of cardiovascular // events and death in people with ... levels well below the current standards used to diagnose ... failure. They tested the participants’ blood looking for specific ...
... United States, is linked to obesity and lack of exercise. It ... properly to metabolize food, especially sugar. Type-I or juvenile diabetes is ... ,In a recent study of 14,600 people, it was ... had nearly an 80 percent lowered risk, while men who drank ...
... According to latest research unhealthy ways of expressing anger ... way of //expressing anger." According to past research, stress ... who do not practice healthy anger or stress management ... nearly 160 adolescents, ages 14 to 17, for three ...
... the population but account for nearly 20 percent of ... risk factor for // suicide in the elderly. New ... in depressed elderly patients. ,Researchers from Cornell ... elderly patients with depression. Some patients were assigned “care ...
Cached Medicine News:
This design features a solid red iris....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Medicine Products: